drugset / Trial / NCT01655056

A Study to Evaluate the Safety and Tolerability of YM150 in Healthy Caucasian and Japanese Male and Female Subjects, and to Assess the Effect That Gender May Have on Its Actions in the Body

NCT01655056

Phase 1 Completed 82 enrolled Astellas Pharma Europe B.V.
RandomizedSingle-groupTriple-blindBasic science

Summary

The study aims to investigate the effect of YM150 and to compare gender and ethnic differences in healthy Caucasian and Japanese male and female subjects.

Timeline

Start
2006-06
Primary completion
2006-11
Completion
2006-11

Drugs

EvaluationDrugModalityDoseRoute
Subject darexaban Small molecule Oral

Indications

No indication recorded.